Coverage rates of the children vaccination programme in Greenland.
Child
Child, Preschool
Cross-Sectional Studies
Female
Greenland
Health Services Accessibility
/ statistics & numerical data
Humans
Infant
Infant, Newborn
Male
Public Health Surveillance
Vaccination
/ statistics & numerical data
Vaccination Coverage
/ statistics & numerical data
Vaccine-Preventable Diseases
/ prevention & control
Vaccines
/ therapeutic use
Greenland
HPV
Vaccinations
WHO
arctic
children
measles
tuberculosis
Journal
International journal of circumpolar health
ISSN: 2242-3982
Titre abrégé: Int J Circumpolar Health
Pays: United States
ID NLM: 9713056
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
2
12
2020
Statut:
ppublish
Résumé
In order to estimate the current coverage rate among all children in Greenland, we conducted an observational cross-sectional study identifying all children in Greenland eligible for a vaccination between 1 March 2018 and 16 June 2019. we found an overall national coverage of 85.4%. The national coverage for the vaccinations given at birth was 97.1%, dropping to 94.3%, 87.7% and 83.6% at ages 3, 5 and 12 months. Among children eligible for the Measles, Mumps and Rubella-vaccinations, the national coverage was 76.9% for children aged 15 months and 64.1% for children aged 4 years, but dropping to 40.9% in the districts. At preschool, the national coverage was 79.9%. Among the 12-year-old, the national coverages of the two vaccinations against Human Papilloma Virus were 88.4% and 71.6%, respectively, and for the three Hepatitis B-vaccinations 89.8%, 84.1% and 69.6%. A subgroup-analysis and test of an SMS-reminder system in Nuuk improved the coverage from 57.8% to 75.5% locally. Overall, we found a high national coverage rate among the newborn in Greenland. The national coverage rates of the remaining vaccinations were below the WHO-recommendations, however with great regional differences.
Identifiants
pubmed: 32000619
doi: 10.1080/22423982.2020.1721983
pmc: PMC7034463
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1721983Références
Int J Circumpolar Health. 2016 Dec 08;75:32903
pubmed: 27938633
Int J Circumpolar Health. 2018 Dec;77(1):1426948
pubmed: 29392992
Vaccine. 2012 Feb 14;30(8):1425-33
pubmed: 22154773
Int J Circumpolar Health. 2010 Dec;69(5):437-47
pubmed: 21118636
EClinicalMedicine. 2018 Aug 29;2-3:37-49
pubmed: 31193566
Vaccine. 2018 Aug 9;36(33):4979-4992
pubmed: 30037416
Gynecol Oncol. 2016 Nov;143(2):307-312
pubmed: 27018418
Thorax. 2014 Sep;69(9):851-6
pubmed: 24969643
Vaccine. 2003 Apr 2;21(15):1704-9
pubmed: 12639493
World J Hepatol. 2015 May 28;7(9):1265-71
pubmed: 26019742
Int J Circumpolar Health. 2014 Jul 11;73:24843
pubmed: 25045654
Am J Prev Med. 2017 Aug;53(2):162-168
pubmed: 28256284
J Natl Cancer Inst. 2011 Nov 16;103(22):1676-85
pubmed: 22021665
Scand J Infect Dis. 2004;36(5):325-9
pubmed: 15287375
Int J Circumpolar Health. 2004;63 Suppl 2:252-5
pubmed: 15736662